Capital Research Global Investors 13D/13G Filings for Abbott Laboratories (ABT)

Capital Research Global Investors 13D and 13G filings for Abbott Laboratories:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
3:46 pm
Sale
2021-02-1613GAbbott Laboratories
ABT
Capital Research Global Investors86,394,199
4.900%
-27,295,094decrease
(-24.01%)
Filing
2020-02-14
12:03 pm
Sale
2019-12-3113GAbbott Laboratories
ABT
Capital Research Global Investors113,689,293
6.400%
-8,239,053decrease
(-6.76%)
Filing